Moors & Cabot Inc. Sells 99 Shares of The Clorox Company (NYSE:CLX)

Moors & Cabot Inc. decreased its holdings in The Clorox Company (NYSE:CLX) by 2.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 3,647 shares of the company’s stock after selling 99 shares during the period. Moors & Cabot Inc.’s holdings in Clorox were worth $594,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Prospera Private Wealth LLC bought a new position in Clorox in the third quarter valued at about $27,000. Innealta Capital LLC acquired a new stake in shares of Clorox in the 2nd quarter valued at approximately $30,000. Trifecta Capital Advisors LLC grew its holdings in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. Quarry LP increased its position in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Finally, Family Firm Inc. bought a new position in Clorox in the 2nd quarter valued at approximately $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

CLX stock opened at $169.31 on Friday. The firm has a market cap of $20.96 billion, a PE ratio of 58.99, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a 50-day moving average price of $162.78 and a 200-day moving average price of $148.43. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.35.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue was up 27.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 earnings per share. As a group, equities research analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.88%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 170.03%.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.57% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the subject of several research analyst reports. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, JPMorgan Chase & Co. boosted their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.